Correction: Thymic Epithelial Tumors at the Crossroads of Immunity, Autoimmunity, and Immunotherapy (Cancer Immunology, Immunotherapy, (2026), 75, 4, (110), 10.1007/S00262-026-04311-4)

Correction: Thymic Epithelial Tumors at the Crossroads of Immunity, Autoimmunity, and Immunotherapy (Cancer Immunology, Immunotherapy, (2026), 75, 4, (110), 10.1007/S00262-026-04311-4) Publisher Pubmed

Canaslan K ; Nia FM ; Baez M ; Abolhassani H ; Ridge N ; Zerdan MB ; Marks J ; Rangoonwala H ; Jahanbin B ; Emami AH ; Oreilly K ; Gokmenpolar Y ; Badve SS ; Xu C Show All Authors

Canaslan K
Nia FM
Baez M
Abolhassani H
Ridge N
Zerdan MB
Marks J
Rangoonwala H
Jahanbin B
Emami AH
Oreilly K
Gokmenpolar Y
Badve SS
Xu C
Hao Y
Sharma A
Upadhya S
Salle FG
Pan K
El Osta B
Shin DM
Ardeshirlarijani F

Source: Cancer Immunology, Immunotherapy Published:2026

Abstract

In the original version of this article, the author’s name Badi El Osta was incorrectly written as Badi El Olsta. © The Author(s) 2026.

Style	Citing Format
MLA	Canaslan K, et al.. "Correction: Thymic Epithelial Tumors at the Crossroads of Immunity, Autoimmunity, and Immunotherapy (Cancer Immunology, Immunotherapy, (2026), 75, 4, (110), 10.1007/S00262-026-04311-4)." Cancer Immunology, Immunotherapy, vol. 75, no. 6, 2026, pp. -.
APA	Canaslan K, Nia FM, Baez M, Abolhassani H, Ridge N, Zerdan MB, Marks J, Rangoonwala H, Jahanbin B, Emami AH, Oreilly K, Gokmenpolar Y, Badve SS, Xu C, Hao Y, Sharma A, Upadhya S, Salle FG, Pan K, ... Ardeshirlarijani F (2026). Correction: Thymic Epithelial Tumors at the Crossroads of Immunity, Autoimmunity, and Immunotherapy (Cancer Immunology, Immunotherapy, (2026), 75, 4, (110), 10.1007/S00262-026-04311-4). Cancer Immunology, Immunotherapy, 75(6), -.
Chicago	Canaslan K, Nia FM, Baez M, Abolhassani H, Ridge N, Zerdan MB, Marks J, et al.. "Correction: Thymic Epithelial Tumors at the Crossroads of Immunity, Autoimmunity, and Immunotherapy (Cancer Immunology, Immunotherapy, (2026), 75, 4, (110), 10.1007/S00262-026-04311-4)." Cancer Immunology, Immunotherapy 75, no. 6 (2026): -.
Harvard	Canaslan K et al. (2026) 'Correction: Thymic Epithelial Tumors at the Crossroads of Immunity, Autoimmunity, and Immunotherapy (Cancer Immunology, Immunotherapy, (2026), 75, 4, (110), 10.1007/S00262-026-04311-4)', Cancer Immunology, Immunotherapy, 75(6), pp. -.
Vancouver	Canaslan K, Nia FM, Baez M, Abolhassani H, Ridge N, Zerdan MB, et al.. Correction: Thymic Epithelial Tumors at the Crossroads of Immunity, Autoimmunity, and Immunotherapy (Cancer Immunology, Immunotherapy, (2026), 75, 4, (110), 10.1007/S00262-026-04311-4). Cancer Immunology, Immunotherapy. 2026;75(6):-.
BibTex	@article{ author = {Canaslan K and Nia FM and Baez M and Abolhassani H and Ridge N and Zerdan MB and Marks J and Rangoonwala H and Jahanbin B and Emami AH and Oreilly K and Gokmenpolar Y and Badve SS and Xu C and Hao Y and Sharma A and Upadhya S and Salle FG and Pan K and El Osta B and Shin DM and Ardeshirlarijani F}, title = {Correction: Thymic Epithelial Tumors at the Crossroads of Immunity, Autoimmunity, and Immunotherapy (Cancer Immunology, Immunotherapy, (2026), 75, 4, (110), 10.1007/S00262-026-04311-4)}, journal = {Cancer Immunology, Immunotherapy}, volume = {75}, number = {6}, pages = {-}, year = {2026} }
RIS	TY - JOUR AU - Canaslan K AU - Nia FM AU - Baez M AU - Abolhassani H AU - Ridge N AU - Zerdan MB AU - Marks J AU - Rangoonwala H AU - Jahanbin B AU - Emami AH AU - Oreilly K AU - Gokmenpolar Y AU - Badve SS AU - Xu C AU - Hao Y AU - Sharma A AU - Upadhya S AU - Salle FG AU - Pan K AU - El Osta B AU - Shin DM AU - Ardeshirlarijani F TI - Correction: Thymic Epithelial Tumors at the Crossroads of Immunity, Autoimmunity, and Immunotherapy (Cancer Immunology, Immunotherapy, (2026), 75, 4, (110), 10.1007/S00262-026-04311-4) JO - Cancer Immunology, Immunotherapy VL - 75 IS - 6 SP - EP - PY - 2026 ER -

Style

Citing Format

MLA

Canaslan K, et al.. "Correction: Thymic Epithelial Tumors at the Crossroads of Immunity, Autoimmunity, and Immunotherapy (Cancer Immunology, Immunotherapy, (2026), 75, 4, (110), 10.1007/S00262-026-04311-4)." Cancer Immunology, Immunotherapy, vol. 75, no. 6, 2026, pp. -.

APA

Canaslan K, Nia FM, Baez M, Abolhassani H, Ridge N, Zerdan MB, Marks J, Rangoonwala H, Jahanbin B, Emami AH, Oreilly K, Gokmenpolar Y, Badve SS, Xu C, Hao Y, Sharma A, Upadhya S, Salle FG, Pan K, ... Ardeshirlarijani F (2026). Correction: Thymic Epithelial Tumors at the Crossroads of Immunity, Autoimmunity, and Immunotherapy (Cancer Immunology, Immunotherapy, (2026), 75, 4, (110), 10.1007/S00262-026-04311-4). Cancer Immunology, Immunotherapy, 75(6), -.

Chicago

Canaslan K, Nia FM, Baez M, Abolhassani H, Ridge N, Zerdan MB, Marks J, et al.. "Correction: Thymic Epithelial Tumors at the Crossroads of Immunity, Autoimmunity, and Immunotherapy (Cancer Immunology, Immunotherapy, (2026), 75, 4, (110), 10.1007/S00262-026-04311-4)." Cancer Immunology, Immunotherapy 75, no. 6 (2026): -.

Harvard

Canaslan K et al. (2026) 'Correction: Thymic Epithelial Tumors at the Crossroads of Immunity, Autoimmunity, and Immunotherapy (Cancer Immunology, Immunotherapy, (2026), 75, 4, (110), 10.1007/S00262-026-04311-4)', Cancer Immunology, Immunotherapy, 75(6), pp. -.

Vancouver

Canaslan K, Nia FM, Baez M, Abolhassani H, Ridge N, Zerdan MB, et al.. Correction: Thymic Epithelial Tumors at the Crossroads of Immunity, Autoimmunity, and Immunotherapy (Cancer Immunology, Immunotherapy, (2026), 75, 4, (110), 10.1007/S00262-026-04311-4). Cancer Immunology, Immunotherapy. 2026;75(6):-.

BibTex

@article{ author = {Canaslan K and Nia FM and Baez M and Abolhassani H and Ridge N and Zerdan MB and Marks J and Rangoonwala H and Jahanbin B and Emami AH and Oreilly K and Gokmenpolar Y and Badve SS and Xu C and Hao Y and Sharma A and Upadhya S and Salle FG and Pan K and El Osta B and Shin DM and Ardeshirlarijani F}, title = {Correction: Thymic Epithelial Tumors at the Crossroads of Immunity, Autoimmunity, and Immunotherapy (Cancer Immunology, Immunotherapy, (2026), 75, 4, (110), 10.1007/S00262-026-04311-4)}, journal = {Cancer Immunology, Immunotherapy}, volume = {75}, number = {6}, pages = {-}, year = {2026} }

RIS

TY - JOUR
AU - Canaslan K
AU - Nia FM
AU - Baez M
AU - Abolhassani H
AU - Ridge N
AU - Zerdan MB
AU - Marks J
AU - Rangoonwala H
AU - Jahanbin B
AU - Emami AH
AU - Oreilly K
AU - Gokmenpolar Y
AU - Badve SS
AU - Xu C
AU - Hao Y
AU - Sharma A
AU - Upadhya S
AU - Salle FG
AU - Pan K
AU - El Osta B
AU - Shin DM
AU - Ardeshirlarijani F
TI - Correction: Thymic Epithelial Tumors at the Crossroads of Immunity, Autoimmunity, and Immunotherapy (Cancer Immunology, Immunotherapy, (2026), 75, 4, (110), 10.1007/S00262-026-04311-4)
JO - Cancer Immunology, Immunotherapy
VL - 75
IS - 6
SP -
EP -
PY - 2026
ER -

Science Communicator Platform

Authors

Abstract